Global Graft Versus Host Disease Treatment Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 111

Published Date: 04 Jan 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Graft Versus Host Disease Treatment market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Graft Versus Host Disease Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Graft Versus Host Disease Treatment market size and forecasts, in consumption value ($ Million), 2018-2029
Global Graft Versus Host Disease Treatment market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Graft Versus Host Disease Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Graft Versus Host Disease Treatment market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Graft Versus Host Disease Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Graft Versus Host Disease Treatment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie Inc., Acrofan, Astellas Pharma Inc., Bristol-Myers Squibb Company and ElsaLys Biotech SA, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Graft Versus Host Disease Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Etanercept
    Monoclonal Antibodies
    Thalidomide
    Tyrosine Kinase Inhibitors
    mTOR Inhibitors

Market segment by Application
    Acute GVHD
    Chronic GVHD
    Prophylaxis GVHD

Market segment by players, this report covers
    AbbVie Inc.
    Acrofan
    Astellas Pharma Inc.
    Bristol-Myers Squibb Company
    ElsaLys Biotech SA
    F. Hoffmann-La Roche AG
    Johnson & Johnson
    Mallinckrodft PLC
    Merck & Co., Inc.
    Mesoblast Limited
    Neovii Biotech GmbH
    Novartis AG
    Ocugen, Inc.
    Pfizer Inc
    Pluristem Therapeutics Inc.
    Samedan Ltd
    Sanofi SA
    Soligenix, Inc.

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Graft Versus Host Disease Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Graft Versus Host Disease Treatment, with revenue, gross margin and global market share of Graft Versus Host Disease Treatment from 2018 to 2023.
Chapter 3, the Graft Versus Host Disease Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Graft Versus Host Disease Treatment market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Graft Versus Host Disease Treatment.
Chapter 13, to describe Graft Versus Host Disease Treatment research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Graft Versus Host Disease Treatment
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Graft Versus Host Disease Treatment by Type
        1.3.1 Overview: Global Graft Versus Host Disease Treatment Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Graft Versus Host Disease Treatment Consumption Value Market Share by Type in 2022
        1.3.3 Etanercept
        1.3.4 Monoclonal Antibodies
        1.3.5 Thalidomide
        1.3.6 Tyrosine Kinase Inhibitors
        1.3.7 mTOR Inhibitors
    1.4 Global Graft Versus Host Disease Treatment Market by Application
        1.4.1 Overview: Global Graft Versus Host Disease Treatment Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Acute GVHD
        1.4.3 Chronic GVHD
        1.4.4 Prophylaxis GVHD
    1.5 Global Graft Versus Host Disease Treatment Market Size & Forecast
    1.6 Global Graft Versus Host Disease Treatment Market Size and Forecast by Region
        1.6.1 Global Graft Versus Host Disease Treatment Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Graft Versus Host Disease Treatment Market Size by Region, (2018-2029)
        1.6.3 North America Graft Versus Host Disease Treatment Market Size and Prospect (2018-2029)
        1.6.4 Europe Graft Versus Host Disease Treatment Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Graft Versus Host Disease Treatment Market Size and Prospect (2018-2029)
        1.6.6 South America Graft Versus Host Disease Treatment Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Graft Versus Host Disease Treatment Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 AbbVie Inc.
        2.1.1 AbbVie Inc. Details
        2.1.2 AbbVie Inc. Major Business
        2.1.3 AbbVie Inc. Graft Versus Host Disease Treatment Product and Solutions
        2.1.4 AbbVie Inc. Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 AbbVie Inc. Recent Developments and Future Plans
    2.2 Acrofan
        2.2.1 Acrofan Details
        2.2.2 Acrofan Major Business
        2.2.3 Acrofan Graft Versus Host Disease Treatment Product and Solutions
        2.2.4 Acrofan Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Acrofan Recent Developments and Future Plans
    2.3 Astellas Pharma Inc.
        2.3.1 Astellas Pharma Inc. Details
        2.3.2 Astellas Pharma Inc. Major Business
        2.3.3 Astellas Pharma Inc. Graft Versus Host Disease Treatment Product and Solutions
        2.3.4 Astellas Pharma Inc. Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Astellas Pharma Inc. Recent Developments and Future Plans
    2.4 Bristol-Myers Squibb Company
        2.4.1 Bristol-Myers Squibb Company Details
        2.4.2 Bristol-Myers Squibb Company Major Business
        2.4.3 Bristol-Myers Squibb Company Graft Versus Host Disease Treatment Product and Solutions
        2.4.4 Bristol-Myers Squibb Company Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Bristol-Myers Squibb Company Recent Developments and Future Plans
    2.5 ElsaLys Biotech SA
        2.5.1 ElsaLys Biotech SA Details
        2.5.2 ElsaLys Biotech SA Major Business
        2.5.3 ElsaLys Biotech SA Graft Versus Host Disease Treatment Product and Solutions
        2.5.4 ElsaLys Biotech SA Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 ElsaLys Biotech SA Recent Developments and Future Plans
    2.6 F. Hoffmann-La Roche AG
        2.6.1 F. Hoffmann-La Roche AG Details
        2.6.2 F. Hoffmann-La Roche AG Major Business
        2.6.3 F. Hoffmann-La Roche AG Graft Versus Host Disease Treatment Product and Solutions
        2.6.4 F. Hoffmann-La Roche AG Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 F. Hoffmann-La Roche AG Recent Developments and Future Plans
    2.7 Johnson & Johnson
        2.7.1 Johnson & Johnson Details
        2.7.2 Johnson & Johnson Major Business
        2.7.3 Johnson & Johnson Graft Versus Host Disease Treatment Product and Solutions
        2.7.4 Johnson & Johnson Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Johnson & Johnson Recent Developments and Future Plans
    2.8 Mallinckrodft PLC
        2.8.1 Mallinckrodft PLC Details
        2.8.2 Mallinckrodft PLC Major Business
        2.8.3 Mallinckrodft PLC Graft Versus Host Disease Treatment Product and Solutions
        2.8.4 Mallinckrodft PLC Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Mallinckrodft PLC Recent Developments and Future Plans
    2.9 Merck & Co., Inc.
        2.9.1 Merck & Co., Inc. Details
        2.9.2 Merck & Co., Inc. Major Business
        2.9.3 Merck & Co., Inc. Graft Versus Host Disease Treatment Product and Solutions
        2.9.4 Merck & Co., Inc. Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Merck & Co., Inc. Recent Developments and Future Plans
    2.10 Mesoblast Limited
        2.10.1 Mesoblast Limited Details
        2.10.2 Mesoblast Limited Major Business
        2.10.3 Mesoblast Limited Graft Versus Host Disease Treatment Product and Solutions
        2.10.4 Mesoblast Limited Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Mesoblast Limited Recent Developments and Future Plans
    2.11 Neovii Biotech GmbH
        2.11.1 Neovii Biotech GmbH Details
        2.11.2 Neovii Biotech GmbH Major Business
        2.11.3 Neovii Biotech GmbH Graft Versus Host Disease Treatment Product and Solutions
        2.11.4 Neovii Biotech GmbH Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Neovii Biotech GmbH Recent Developments and Future Plans
    2.12 Novartis AG
        2.12.1 Novartis AG Details
        2.12.2 Novartis AG Major Business
        2.12.3 Novartis AG Graft Versus Host Disease Treatment Product and Solutions
        2.12.4 Novartis AG Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Novartis AG Recent Developments and Future Plans
    2.13 Ocugen, Inc.
        2.13.1 Ocugen, Inc. Details
        2.13.2 Ocugen, Inc. Major Business
        2.13.3 Ocugen, Inc. Graft Versus Host Disease Treatment Product and Solutions
        2.13.4 Ocugen, Inc. Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Ocugen, Inc. Recent Developments and Future Plans
    2.14 Pfizer Inc
        2.14.1 Pfizer Inc Details
        2.14.2 Pfizer Inc Major Business
        2.14.3 Pfizer Inc Graft Versus Host Disease Treatment Product and Solutions
        2.14.4 Pfizer Inc Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Pfizer Inc Recent Developments and Future Plans
    2.15 Pluristem Therapeutics Inc.
        2.15.1 Pluristem Therapeutics Inc. Details
        2.15.2 Pluristem Therapeutics Inc. Major Business
        2.15.3 Pluristem Therapeutics Inc. Graft Versus Host Disease Treatment Product and Solutions
        2.15.4 Pluristem Therapeutics Inc. Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 Pluristem Therapeutics Inc. Recent Developments and Future Plans
    2.16 Samedan Ltd
        2.16.1 Samedan Ltd Details
        2.16.2 Samedan Ltd Major Business
        2.16.3 Samedan Ltd Graft Versus Host Disease Treatment Product and Solutions
        2.16.4 Samedan Ltd Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.16.5 Samedan Ltd Recent Developments and Future Plans
    2.17 Sanofi SA
        2.17.1 Sanofi SA Details
        2.17.2 Sanofi SA Major Business
        2.17.3 Sanofi SA Graft Versus Host Disease Treatment Product and Solutions
        2.17.4 Sanofi SA Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.17.5 Sanofi SA Recent Developments and Future Plans
    2.18 Soligenix, Inc.
        2.18.1 Soligenix, Inc. Details
        2.18.2 Soligenix, Inc. Major Business
        2.18.3 Soligenix, Inc. Graft Versus Host Disease Treatment Product and Solutions
        2.18.4 Soligenix, Inc. Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.18.5 Soligenix, Inc. Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Graft Versus Host Disease Treatment Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Graft Versus Host Disease Treatment by Company Revenue
        3.2.2 Top 3 Graft Versus Host Disease Treatment Players Market Share in 2022
        3.2.3 Top 6 Graft Versus Host Disease Treatment Players Market Share in 2022
    3.3 Graft Versus Host Disease Treatment Market: Overall Company Footprint Analysis
        3.3.1 Graft Versus Host Disease Treatment Market: Region Footprint
        3.3.2 Graft Versus Host Disease Treatment Market: Company Product Type Footprint
        3.3.3 Graft Versus Host Disease Treatment Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Graft Versus Host Disease Treatment Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Graft Versus Host Disease Treatment Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Graft Versus Host Disease Treatment Consumption Value Market Share by Application (2018-2023)
    5.2 Global Graft Versus Host Disease Treatment Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Graft Versus Host Disease Treatment Consumption Value by Type (2018-2029)
    6.2 North America Graft Versus Host Disease Treatment Consumption Value by Application (2018-2029)
    6.3 North America Graft Versus Host Disease Treatment Market Size by Country
        6.3.1 North America Graft Versus Host Disease Treatment Consumption Value by Country (2018-2029)
        6.3.2 United States Graft Versus Host Disease Treatment Market Size and Forecast (2018-2029)
        6.3.3 Canada Graft Versus Host Disease Treatment Market Size and Forecast (2018-2029)
        6.3.4 Mexico Graft Versus Host Disease Treatment Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Graft Versus Host Disease Treatment Consumption Value by Type (2018-2029)
    7.2 Europe Graft Versus Host Disease Treatment Consumption Value by Application (2018-2029)
    7.3 Europe Graft Versus Host Disease Treatment Market Size by Country
        7.3.1 Europe Graft Versus Host Disease Treatment Consumption Value by Country (2018-2029)
        7.3.2 Germany Graft Versus Host Disease Treatment Market Size and Forecast (2018-2029)
        7.3.3 France Graft Versus Host Disease Treatment Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Graft Versus Host Disease Treatment Market Size and Forecast (2018-2029)
        7.3.5 Russia Graft Versus Host Disease Treatment Market Size and Forecast (2018-2029)
        7.3.6 Italy Graft Versus Host Disease Treatment Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Graft Versus Host Disease Treatment Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Graft Versus Host Disease Treatment Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Graft Versus Host Disease Treatment Market Size by Region
        8.3.1 Asia-Pacific Graft Versus Host Disease Treatment Consumption Value by Region (2018-2029)
        8.3.2 China Graft Versus Host Disease Treatment Market Size and Forecast (2018-2029)
        8.3.3 Japan Graft Versus Host Disease Treatment Market Size and Forecast (2018-2029)
        8.3.4 South Korea Graft Versus Host Disease Treatment Market Size and Forecast (2018-2029)
        8.3.5 India Graft Versus Host Disease Treatment Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Graft Versus Host Disease Treatment Market Size and Forecast (2018-2029)
        8.3.7 Australia Graft Versus Host Disease Treatment Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Graft Versus Host Disease Treatment Consumption Value by Type (2018-2029)
    9.2 South America Graft Versus Host Disease Treatment Consumption Value by Application (2018-2029)
    9.3 South America Graft Versus Host Disease Treatment Market Size by Country
        9.3.1 South America Graft Versus Host Disease Treatment Consumption Value by Country (2018-2029)
        9.3.2 Brazil Graft Versus Host Disease Treatment Market Size and Forecast (2018-2029)
        9.3.3 Argentina Graft Versus Host Disease Treatment Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Graft Versus Host Disease Treatment Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Graft Versus Host Disease Treatment Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Graft Versus Host Disease Treatment Market Size by Country
        10.3.1 Middle East & Africa Graft Versus Host Disease Treatment Consumption Value by Country (2018-2029)
        10.3.2 Turkey Graft Versus Host Disease Treatment Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Graft Versus Host Disease Treatment Market Size and Forecast (2018-2029)
        10.3.4 UAE Graft Versus Host Disease Treatment Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Graft Versus Host Disease Treatment Market Drivers
    11.2 Graft Versus Host Disease Treatment Market Restraints
    11.3 Graft Versus Host Disease Treatment Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Graft Versus Host Disease Treatment Industry Chain
    12.2 Graft Versus Host Disease Treatment Upstream Analysis
    12.3 Graft Versus Host Disease Treatment Midstream Analysis
    12.4 Graft Versus Host Disease Treatment Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Graft Versus Host Disease Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Graft Versus Host Disease Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Graft Versus Host Disease Treatment Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Graft Versus Host Disease Treatment Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. AbbVie Inc. Company Information, Head Office, and Major Competitors
    Table 6. AbbVie Inc. Major Business
    Table 7. AbbVie Inc. Graft Versus Host Disease Treatment Product and Solutions
    Table 8. AbbVie Inc. Graft Versus Host Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. AbbVie Inc. Recent Developments and Future Plans
    Table 10. Acrofan Company Information, Head Office, and Major Competitors
    Table 11. Acrofan Major Business
    Table 12. Acrofan Graft Versus Host Disease Treatment Product and Solutions
    Table 13. Acrofan Graft Versus Host Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Acrofan Recent Developments and Future Plans
    Table 15. Astellas Pharma Inc. Company Information, Head Office, and Major Competitors
    Table 16. Astellas Pharma Inc. Major Business
    Table 17. Astellas Pharma Inc. Graft Versus Host Disease Treatment Product and Solutions
    Table 18. Astellas Pharma Inc. Graft Versus Host Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Astellas Pharma Inc. Recent Developments and Future Plans
    Table 20. Bristol-Myers Squibb Company Company Information, Head Office, and Major Competitors
    Table 21. Bristol-Myers Squibb Company Major Business
    Table 22. Bristol-Myers Squibb Company Graft Versus Host Disease Treatment Product and Solutions
    Table 23. Bristol-Myers Squibb Company Graft Versus Host Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Bristol-Myers Squibb Company Recent Developments and Future Plans
    Table 25. ElsaLys Biotech SA Company Information, Head Office, and Major Competitors
    Table 26. ElsaLys Biotech SA Major Business
    Table 27. ElsaLys Biotech SA Graft Versus Host Disease Treatment Product and Solutions
    Table 28. ElsaLys Biotech SA Graft Versus Host Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. ElsaLys Biotech SA Recent Developments and Future Plans
    Table 30. F. Hoffmann-La Roche AG Company Information, Head Office, and Major Competitors
    Table 31. F. Hoffmann-La Roche AG Major Business
    Table 32. F. Hoffmann-La Roche AG Graft Versus Host Disease Treatment Product and Solutions
    Table 33. F. Hoffmann-La Roche AG Graft Versus Host Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. F. Hoffmann-La Roche AG Recent Developments and Future Plans
    Table 35. Johnson & Johnson Company Information, Head Office, and Major Competitors
    Table 36. Johnson & Johnson Major Business
    Table 37. Johnson & Johnson Graft Versus Host Disease Treatment Product and Solutions
    Table 38. Johnson & Johnson Graft Versus Host Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Johnson & Johnson Recent Developments and Future Plans
    Table 40. Mallinckrodft PLC Company Information, Head Office, and Major Competitors
    Table 41. Mallinckrodft PLC Major Business
    Table 42. Mallinckrodft PLC Graft Versus Host Disease Treatment Product and Solutions
    Table 43. Mallinckrodft PLC Graft Versus Host Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Mallinckrodft PLC Recent Developments and Future Plans
    Table 45. Merck & Co., Inc. Company Information, Head Office, and Major Competitors
    Table 46. Merck & Co., Inc. Major Business
    Table 47. Merck & Co., Inc. Graft Versus Host Disease Treatment Product and Solutions
    Table 48. Merck & Co., Inc. Graft Versus Host Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Merck & Co., Inc. Recent Developments and Future Plans
    Table 50. Mesoblast Limited Company Information, Head Office, and Major Competitors
    Table 51. Mesoblast Limited Major Business
    Table 52. Mesoblast Limited Graft Versus Host Disease Treatment Product and Solutions
    Table 53. Mesoblast Limited Graft Versus Host Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Mesoblast Limited Recent Developments and Future Plans
    Table 55. Neovii Biotech GmbH Company Information, Head Office, and Major Competitors
    Table 56. Neovii Biotech GmbH Major Business
    Table 57. Neovii Biotech GmbH Graft Versus Host Disease Treatment Product and Solutions
    Table 58. Neovii Biotech GmbH Graft Versus Host Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. Neovii Biotech GmbH Recent Developments and Future Plans
    Table 60. Novartis AG Company Information, Head Office, and Major Competitors
    Table 61. Novartis AG Major Business
    Table 62. Novartis AG Graft Versus Host Disease Treatment Product and Solutions
    Table 63. Novartis AG Graft Versus Host Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. Novartis AG Recent Developments and Future Plans
    Table 65. Ocugen, Inc. Company Information, Head Office, and Major Competitors
    Table 66. Ocugen, Inc. Major Business
    Table 67. Ocugen, Inc. Graft Versus Host Disease Treatment Product and Solutions
    Table 68. Ocugen, Inc. Graft Versus Host Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 69. Ocugen, Inc. Recent Developments and Future Plans
    Table 70. Pfizer Inc Company Information, Head Office, and Major Competitors
    Table 71. Pfizer Inc Major Business
    Table 72. Pfizer Inc Graft Versus Host Disease Treatment Product and Solutions
    Table 73. Pfizer Inc Graft Versus Host Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 74. Pfizer Inc Recent Developments and Future Plans
    Table 75. Pluristem Therapeutics Inc. Company Information, Head Office, and Major Competitors
    Table 76. Pluristem Therapeutics Inc. Major Business
    Table 77. Pluristem Therapeutics Inc. Graft Versus Host Disease Treatment Product and Solutions
    Table 78. Pluristem Therapeutics Inc. Graft Versus Host Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 79. Pluristem Therapeutics Inc. Recent Developments and Future Plans
    Table 80. Samedan Ltd Company Information, Head Office, and Major Competitors
    Table 81. Samedan Ltd Major Business
    Table 82. Samedan Ltd Graft Versus Host Disease Treatment Product and Solutions
    Table 83. Samedan Ltd Graft Versus Host Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 84. Samedan Ltd Recent Developments and Future Plans
    Table 85. Sanofi SA Company Information, Head Office, and Major Competitors
    Table 86. Sanofi SA Major Business
    Table 87. Sanofi SA Graft Versus Host Disease Treatment Product and Solutions
    Table 88. Sanofi SA Graft Versus Host Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Sanofi SA Recent Developments and Future Plans
    Table 90. Soligenix, Inc. Company Information, Head Office, and Major Competitors
    Table 91. Soligenix, Inc. Major Business
    Table 92. Soligenix, Inc. Graft Versus Host Disease Treatment Product and Solutions
    Table 93. Soligenix, Inc. Graft Versus Host Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 94. Soligenix, Inc. Recent Developments and Future Plans
    Table 95. Global Graft Versus Host Disease Treatment Revenue (USD Million) by Players (2018-2023)
    Table 96. Global Graft Versus Host Disease Treatment Revenue Share by Players (2018-2023)
    Table 97. Breakdown of Graft Versus Host Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 98. Market Position of Players in Graft Versus Host Disease Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 99. Head Office of Key Graft Versus Host Disease Treatment Players
    Table 100. Graft Versus Host Disease Treatment Market: Company Product Type Footprint
    Table 101. Graft Versus Host Disease Treatment Market: Company Product Application Footprint
    Table 102. Graft Versus Host Disease Treatment New Market Entrants and Barriers to Market Entry
    Table 103. Graft Versus Host Disease Treatment Mergers, Acquisition, Agreements, and Collaborations
    Table 104. Global Graft Versus Host Disease Treatment Consumption Value (USD Million) by Type (2018-2023)
    Table 105. Global Graft Versus Host Disease Treatment Consumption Value Share by Type (2018-2023)
    Table 106. Global Graft Versus Host Disease Treatment Consumption Value Forecast by Type (2024-2029)
    Table 107. Global Graft Versus Host Disease Treatment Consumption Value by Application (2018-2023)
    Table 108. Global Graft Versus Host Disease Treatment Consumption Value Forecast by Application (2024-2029)
    Table 109. North America Graft Versus Host Disease Treatment Consumption Value by Type (2018-2023) & (USD Million)
    Table 110. North America Graft Versus Host Disease Treatment Consumption Value by Type (2024-2029) & (USD Million)
    Table 111. North America Graft Versus Host Disease Treatment Consumption Value by Application (2018-2023) & (USD Million)
    Table 112. North America Graft Versus Host Disease Treatment Consumption Value by Application (2024-2029) & (USD Million)
    Table 113. North America Graft Versus Host Disease Treatment Consumption Value by Country (2018-2023) & (USD Million)
    Table 114. North America Graft Versus Host Disease Treatment Consumption Value by Country (2024-2029) & (USD Million)
    Table 115. Europe Graft Versus Host Disease Treatment Consumption Value by Type (2018-2023) & (USD Million)
    Table 116. Europe Graft Versus Host Disease Treatment Consumption Value by Type (2024-2029) & (USD Million)
    Table 117. Europe Graft Versus Host Disease Treatment Consumption Value by Application (2018-2023) & (USD Million)
    Table 118. Europe Graft Versus Host Disease Treatment Consumption Value by Application (2024-2029) & (USD Million)
    Table 119. Europe Graft Versus Host Disease Treatment Consumption Value by Country (2018-2023) & (USD Million)
    Table 120. Europe Graft Versus Host Disease Treatment Consumption Value by Country (2024-2029) & (USD Million)
    Table 121. Asia-Pacific Graft Versus Host Disease Treatment Consumption Value by Type (2018-2023) & (USD Million)
    Table 122. Asia-Pacific Graft Versus Host Disease Treatment Consumption Value by Type (2024-2029) & (USD Million)
    Table 123. Asia-Pacific Graft Versus Host Disease Treatment Consumption Value by Application (2018-2023) & (USD Million)
    Table 124. Asia-Pacific Graft Versus Host Disease Treatment Consumption Value by Application (2024-2029) & (USD Million)
    Table 125. Asia-Pacific Graft Versus Host Disease Treatment Consumption Value by Region (2018-2023) & (USD Million)
    Table 126. Asia-Pacific Graft Versus Host Disease Treatment Consumption Value by Region (2024-2029) & (USD Million)
    Table 127. South America Graft Versus Host Disease Treatment Consumption Value by Type (2018-2023) & (USD Million)
    Table 128. South America Graft Versus Host Disease Treatment Consumption Value by Type (2024-2029) & (USD Million)
    Table 129. South America Graft Versus Host Disease Treatment Consumption Value by Application (2018-2023) & (USD Million)
    Table 130. South America Graft Versus Host Disease Treatment Consumption Value by Application (2024-2029) & (USD Million)
    Table 131. South America Graft Versus Host Disease Treatment Consumption Value by Country (2018-2023) & (USD Million)
    Table 132. South America Graft Versus Host Disease Treatment Consumption Value by Country (2024-2029) & (USD Million)
    Table 133. Middle East & Africa Graft Versus Host Disease Treatment Consumption Value by Type (2018-2023) & (USD Million)
    Table 134. Middle East & Africa Graft Versus Host Disease Treatment Consumption Value by Type (2024-2029) & (USD Million)
    Table 135. Middle East & Africa Graft Versus Host Disease Treatment Consumption Value by Application (2018-2023) & (USD Million)
    Table 136. Middle East & Africa Graft Versus Host Disease Treatment Consumption Value by Application (2024-2029) & (USD Million)
    Table 137. Middle East & Africa Graft Versus Host Disease Treatment Consumption Value by Country (2018-2023) & (USD Million)
    Table 138. Middle East & Africa Graft Versus Host Disease Treatment Consumption Value by Country (2024-2029) & (USD Million)
    Table 139. Graft Versus Host Disease Treatment Raw Material
    Table 140. Key Suppliers of Graft Versus Host Disease Treatment Raw Materials
List of Figures
    Figure 1. Graft Versus Host Disease Treatment Picture
    Figure 2. Global Graft Versus Host Disease Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Graft Versus Host Disease Treatment Consumption Value Market Share by Type in 2022
    Figure 4. Etanercept
    Figure 5. Monoclonal Antibodies
    Figure 6. Thalidomide
    Figure 7. Tyrosine Kinase Inhibitors
    Figure 8. mTOR Inhibitors
    Figure 9. Global Graft Versus Host Disease Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 10. Graft Versus Host Disease Treatment Consumption Value Market Share by Application in 2022
    Figure 11. Acute GVHD Picture
    Figure 12. Chronic GVHD Picture
    Figure 13. Prophylaxis GVHD Picture
    Figure 14. Global Graft Versus Host Disease Treatment Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 15. Global Graft Versus Host Disease Treatment Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 16. Global Market Graft Versus Host Disease Treatment Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 17. Global Graft Versus Host Disease Treatment Consumption Value Market Share by Region (2018-2029)
    Figure 18. Global Graft Versus Host Disease Treatment Consumption Value Market Share by Region in 2022
    Figure 19. North America Graft Versus Host Disease Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 20. Europe Graft Versus Host Disease Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 21. Asia-Pacific Graft Versus Host Disease Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 22. South America Graft Versus Host Disease Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 23. Middle East and Africa Graft Versus Host Disease Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 24. Global Graft Versus Host Disease Treatment Revenue Share by Players in 2022
    Figure 25. Graft Versus Host Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 26. Global Top 3 Players Graft Versus Host Disease Treatment Market Share in 2022
    Figure 27. Global Top 6 Players Graft Versus Host Disease Treatment Market Share in 2022
    Figure 28. Global Graft Versus Host Disease Treatment Consumption Value Share by Type (2018-2023)
    Figure 29. Global Graft Versus Host Disease Treatment Market Share Forecast by Type (2024-2029)
    Figure 30. Global Graft Versus Host Disease Treatment Consumption Value Share by Application (2018-2023)
    Figure 31. Global Graft Versus Host Disease Treatment Market Share Forecast by Application (2024-2029)
    Figure 32. North America Graft Versus Host Disease Treatment Consumption Value Market Share by Type (2018-2029)
    Figure 33. North America Graft Versus Host Disease Treatment Consumption Value Market Share by Application (2018-2029)
    Figure 34. North America Graft Versus Host Disease Treatment Consumption Value Market Share by Country (2018-2029)
    Figure 35. United States Graft Versus Host Disease Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 36. Canada Graft Versus Host Disease Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 37. Mexico Graft Versus Host Disease Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 38. Europe Graft Versus Host Disease Treatment Consumption Value Market Share by Type (2018-2029)
    Figure 39. Europe Graft Versus Host Disease Treatment Consumption Value Market Share by Application (2018-2029)
    Figure 40. Europe Graft Versus Host Disease Treatment Consumption Value Market Share by Country (2018-2029)
    Figure 41. Germany Graft Versus Host Disease Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 42. France Graft Versus Host Disease Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 43. United Kingdom Graft Versus Host Disease Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 44. Russia Graft Versus Host Disease Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 45. Italy Graft Versus Host Disease Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 46. Asia-Pacific Graft Versus Host Disease Treatment Consumption Value Market Share by Type (2018-2029)
    Figure 47. Asia-Pacific Graft Versus Host Disease Treatment Consumption Value Market Share by Application (2018-2029)
    Figure 48. Asia-Pacific Graft Versus Host Disease Treatment Consumption Value Market Share by Region (2018-2029)
    Figure 49. China Graft Versus Host Disease Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 50. Japan Graft Versus Host Disease Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 51. South Korea Graft Versus Host Disease Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 52. India Graft Versus Host Disease Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 53. Southeast Asia Graft Versus Host Disease Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 54. Australia Graft Versus Host Disease Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 55. South America Graft Versus Host Disease Treatment Consumption Value Market Share by Type (2018-2029)
    Figure 56. South America Graft Versus Host Disease Treatment Consumption Value Market Share by Application (2018-2029)
    Figure 57. South America Graft Versus Host Disease Treatment Consumption Value Market Share by Country (2018-2029)
    Figure 58. Brazil Graft Versus Host Disease Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 59. Argentina Graft Versus Host Disease Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 60. Middle East and Africa Graft Versus Host Disease Treatment Consumption Value Market Share by Type (2018-2029)
    Figure 61. Middle East and Africa Graft Versus Host Disease Treatment Consumption Value Market Share by Application (2018-2029)
    Figure 62. Middle East and Africa Graft Versus Host Disease Treatment Consumption Value Market Share by Country (2018-2029)
    Figure 63. Turkey Graft Versus Host Disease Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 64. Saudi Arabia Graft Versus Host Disease Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 65. UAE Graft Versus Host Disease Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 66. Graft Versus Host Disease Treatment Market Drivers
    Figure 67. Graft Versus Host Disease Treatment Market Restraints
    Figure 68. Graft Versus Host Disease Treatment Market Trends
    Figure 69. Porters Five Forces Analysis
    Figure 70. Manufacturing Cost Structure Analysis of Graft Versus Host Disease Treatment in 2022
    Figure 71. Manufacturing Process Analysis of Graft Versus Host Disease Treatment
    Figure 72. Graft Versus Host Disease Treatment Industrial Chain
    Figure 73. Methodology
    Figure 74. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Graft Versus Host Disease Treatment Supply, Demand and Key Producers, 2023-2029

Global Graft Versus Host Disease Treatment Supply, Demand and Key Producers, 2023-2029

date 05 Feb 2023

date Medical Care

The global Graft Versus Host Disease Treatment market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Graft Versus Host Disease Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Graft Versus Host Disease Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 23 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Graft Versus Host Disease Treatment market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Graft Versus Host Disease Treatment

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>